Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Other Non-Current Liabilities: 2014-2025

Historic Other Non-Current Liabilities for Viridian Therapeutics, Inc.\DE (VRDN) over the last 10 years, with Sep 2025 value amounting to $2.6 million.

  • Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities rose 19.48% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 19.48%. This contributed to the annual value of $2.3 million for FY2024, which is 133.37% up from last year.
  • According to the latest figures from Q3 2025, Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities is $2.6 million, which was up 24.31% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities ranged from a high of $2.6 million in Q3 2025 and a low of $33,000 during Q1 2021.
  • Its 3-year average for Other Non-Current Liabilities is $1.7 million, with a median of $1.6 million in 2024.
  • The largest annual percentage gain for Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities in the last 5 years was 3,112.12% (2022), contrasted with its biggest fall of 64.26% (2022).
  • Viridian Therapeutics, Inc.\DE's Other Non-Current Liabilities (Quarterly) stood at $1.2 million in 2021, then declined by 2.98% to $1.2 million in 2022, then declined by 15.61% to $989,000 in 2023, then surged by 133.37% to $2.3 million in 2024, then increased by 19.48% to $2.6 million in 2025.
  • Its Other Non-Current Liabilities was $2.6 million in Q3 2025, compared to $2.1 million in Q2 2025 and $1.9 million in Q1 2025.